NO335317B1 - Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor - Google Patents

Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor Download PDF

Info

Publication number
NO335317B1
NO335317B1 NO20044573A NO20044573A NO335317B1 NO 335317 B1 NO335317 B1 NO 335317B1 NO 20044573 A NO20044573 A NO 20044573A NO 20044573 A NO20044573 A NO 20044573A NO 335317 B1 NO335317 B1 NO 335317B1
Authority
NO
Norway
Prior art keywords
tumor
arsenite
treatment
pharmaceutical composition
preparation
Prior art date
Application number
NO20044573A
Other languages
English (en)
Norwegian (no)
Other versions
NO20044573L (no
Inventor
Sang Bong Lee
Yong Jin Yang
Original Assignee
Sang Bong Lee
Yong Jin Yang
Komipharm Int Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29244880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO335317(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sang Bong Lee, Yong Jin Yang, Komipharm Int Co Ltd filed Critical Sang Bong Lee
Publication of NO20044573L publication Critical patent/NO20044573L/no
Publication of NO335317B1 publication Critical patent/NO335317B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20044573A 2002-04-10 2004-10-22 Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor NO335317B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2002/000231 WO2003086424A1 (en) 2002-04-10 2002-04-10 Pharmaceutical composition comprising arsenite for the treatment of malignancy

Publications (2)

Publication Number Publication Date
NO20044573L NO20044573L (no) 2004-10-22
NO335317B1 true NO335317B1 (no) 2014-11-10

Family

ID=29244880

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044573A NO335317B1 (no) 2002-04-10 2004-10-22 Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor

Country Status (25)

Country Link
US (1) US20050106262A1 (cg-RX-API-DMAC7.html)
EP (2) EP2042182B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005525397A (cg-RX-API-DMAC7.html)
CN (1) CN1298332C (cg-RX-API-DMAC7.html)
AP (1) AP2004003167A0 (cg-RX-API-DMAC7.html)
AU (2) AU2002253713B2 (cg-RX-API-DMAC7.html)
BG (1) BG66356B1 (cg-RX-API-DMAC7.html)
BR (1) BR0215689A (cg-RX-API-DMAC7.html)
CA (1) CA2481602C (cg-RX-API-DMAC7.html)
CY (1) CY1114422T1 (cg-RX-API-DMAC7.html)
DK (2) DK2042182T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP045408A (cg-RX-API-DMAC7.html)
ES (2) ES2425418T3 (cg-RX-API-DMAC7.html)
FI (1) FI1496918T3 (cg-RX-API-DMAC7.html)
HU (1) HU230851B1 (cg-RX-API-DMAC7.html)
IL (2) IL164470A0 (cg-RX-API-DMAC7.html)
LT (1) LT1496918T (cg-RX-API-DMAC7.html)
MX (1) MXPA04009898A (cg-RX-API-DMAC7.html)
NO (1) NO335317B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ536452A (cg-RX-API-DMAC7.html)
PT (2) PT2042182E (cg-RX-API-DMAC7.html)
RO (1) RO123269B1 (cg-RX-API-DMAC7.html)
TN (1) TNSN04198A1 (cg-RX-API-DMAC7.html)
UA (1) UA80426C2 (cg-RX-API-DMAC7.html)
WO (1) WO2003086424A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006024492A2 (en) * 2004-08-30 2006-03-09 Interstitial Therapeutics Medical implant provided with inhibitors of atp synthesis
EP1721615A1 (en) 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8945505B2 (en) 2007-02-02 2015-02-03 Panaphix, Inc. Use of arsenic compounds for treatment of pain and inflammation
US20090246291A1 (en) * 2008-03-27 2009-10-01 Angelika Burger Method and compositions for treatment of cancer
US20100249210A1 (en) * 2008-09-30 2010-09-30 Michael Bastiani Methods and compositions related to dlk-1 and the p38 mapk pathway in nerve regeneration
CN102060722B (zh) * 2009-05-01 2014-06-11 常州高新技术产业开发区三维工业技术研究所有限公司 一种含砷化合物及其制备方法和用途
CA2772411C (en) * 2009-09-10 2017-08-22 Kominox, Inc. Cancer stem cell-targeted and drug resistant cancer therapy
EP2477635A4 (en) * 2009-09-18 2013-03-27 Kominox Inc METHODS OF TREATING CEREBRAL TUMORS
CN101695501B (zh) * 2009-10-10 2013-08-14 广汉恒宇新材料有限公司 一种纳米尺寸亚砷酸的壳聚糖包载体及其制造方法
KR102868121B1 (ko) 2018-03-22 2025-10-14 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 메타 아비산염을 포함하는 약학 조성물 및 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804928B1 (en) * 1994-02-18 2004-10-20 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
US6875451B2 (en) * 1997-10-15 2005-04-05 Polarx Biopharmaceuticals Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
CN1119152C (zh) * 1998-08-02 2003-08-27 哈尔滨医科大学第一临床医学院 治疗消化系统肿瘤注射液及其应用

Also Published As

Publication number Publication date
DK2042182T3 (da) 2013-08-26
MXPA04009898A (es) 2005-06-20
BR0215689A (pt) 2005-02-01
ES2944907T3 (es) 2023-06-27
EP2042182B1 (en) 2013-05-22
CA2481602A1 (en) 2003-10-23
ECSP045408A (es) 2006-03-01
US20050106262A1 (en) 2005-05-19
CY1114422T1 (el) 2016-08-31
PT2042182E (pt) 2013-08-28
DK1496918T3 (da) 2023-05-15
NZ536452A (en) 2007-06-29
PT1496918T (pt) 2023-05-25
EP1496918B1 (en) 2023-02-08
BG108932A (en) 2005-11-30
BG66356B1 (bg) 2013-09-30
HU230851B1 (en) 2018-09-28
EP2042182A1 (en) 2009-04-01
AU2008255139B2 (en) 2013-10-03
IL164470A (en) 2010-12-30
IL164470A0 (en) 2005-12-18
AU2008255139A1 (en) 2009-01-08
TNSN04198A1 (en) 2007-03-12
RO123269B1 (ro) 2011-05-30
HUP0500199A2 (en) 2007-02-28
WO2003086424A1 (en) 2003-10-23
CN1625407A (zh) 2005-06-08
HUP0500199A3 (en) 2008-03-28
CN1298332C (zh) 2007-02-07
ES2425418T3 (es) 2013-10-15
EP1496918A1 (en) 2005-01-19
JP2005525397A (ja) 2005-08-25
AP2004003167A0 (en) 2004-12-31
AU2002253713B2 (en) 2008-09-18
AU2002253713A1 (en) 2003-10-27
UA80426C2 (en) 2007-09-25
LT1496918T (lt) 2023-05-25
NO20044573L (no) 2004-10-22
CA2481602C (en) 2011-06-21
FI1496918T3 (fi) 2023-05-11

Similar Documents

Publication Publication Date Title
JP2748333B2 (ja) 抗腫瘍性、抗ウイルス性、抗レトロウイルス性および殺虫性スペルミン誘導体
Ng et al. Synthesis, characterization, DNA-binding study and anticancer properties of ternary metal (II) complexes of edda and an intercalating ligand
Mitsui et al. Antitumor activity of polyoxomolybdate,[NH3Pri] 6 [Mo7O24]· 3H2O, against, human gastric cancer model
RU2106146C1 (ru) Средство для подавления опухолевого роста
NO335317B1 (no) Anvendelse av natrium meta-arsenitt (NaAsO2) for fremstilling av en farmasøytisk sammensetning for behandling av en fast tumor
Wright et al. Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4, 5, 6, 7-tetrachlorobenzimidazole against antibiotic resistant bacteria
Antwi-Baah et al. Morphology-size map of zeolitic imidazolate frameworks: Unveiling the bactericidal effects upon varying their zinc/cobalt ion contents
Karadağ et al. In vitro biological properties and predicted DNA–BSA interaction of three new dicyanidoargentate (i)-based complexes: synthesis and characterization
Santi et al. Antimicrobial evaluation of new metallic complexes with xylitol active against P. aeruginosa and C. albicans: MIC determination, post-agent effect and Zn-uptake
Kincses et al. Selenocompounds as Potent Efflux Pump Inhibitors on Gram‐positive Bacteria
Kargar et al. Recent Advances in the Antimicrobial Activity of Zn (II) Schiff Base Complexes
Bologna et al. Water-soluble platinum phthalocyanines as potential antitumor agents
Cesar et al. Synthesis, characterization, cytotoxic activity, and cellular accumulation of dinuclear platinum complexes derived from N, N′-di-(2-aminoethyl)-1, 3-diamino-2-propanol, aryl substituted N-benzyl-1, 4-butanediamines, and N-benzyl-1, 6-hexanediamines
Aziz et al. Synthesis, crystal structure, antibacterial, cytotoxic, and anticancer activities of new Pd (II) complexes of tri-p-tolyl phosphine with thiones
RU2277908C1 (ru) Водорастворимое средство, обладающее противовирусной активностью, на основе соединения серебра с цистином и способ его получения
RU2358721C1 (ru) Антинеопластический препарат (варианты)
Keypour et al. Anticancer, antioxidant, and antimicrobial studies and molecular docking of a new hexanuclear Zn (ii) complex, together with its X-ray crystal analysis
AU2008258216A1 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
RU2114623C1 (ru) Способ подавления опухолевого роста
CN1523018A (zh) 杂多酸5－氟尿嘧啶盐类抗肿瘤药物及其合成方法
CN104114570B (zh) 作为人免疫缺陷病毒hiv-1产生的选择性抑制剂的氨基甲酰基膦酸酯盐
Gholivand et al. Synthesis, characterization, biological properties, and molecular docking studies of new phosphoramide-based Ag (i) complexes
ZA200408114B (en) Pharmaceutical compositions comprising arsenite for the treatment of malignancy
Benedetti et al. Design, Synthesis, and Anticancer Activity of Fluorescent-Based Dual Function trans-Platinum-NBD Complexes
SINGH et al. Mitochondria as a target for combination cancer-chemotherapy

Legal Events

Date Code Title Description
MK1K Patent expired